Autism

McLean Hospital at Harvard to initiate brain imaging study of secretin

Published in Pain and Central Nervous System Week, March 11th, 2002

Repligen Corp. (RGEN) announced a clinical trial to assess the neurological activity of secretin by functional magnetic resonance imaging (fMRI). The study is being conducted in collaboration with the Brain Imaging Center at McLean Hospital, a teaching affiliate of Harvard Medical School.

The trial will assess the impact of a single injection of secretin or a placebo on the activity of the amygdala, a social integration center in the brain, in 12 healthy adults. Subjects will also perform facial recognition tasks to determine if a single injection of secretin affects this aspect of social awareness. This study is part of a comprehensive clinical program to evaluate...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Pain and Central Nervous System Week

Source: Pain and Central Nervous System Week (2002-03-11)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry